Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study
Crossref DOI link: https://doi.org/10.1007/s13300-018-0483-4
Published Online: 2018-08-17
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jermendy, György http://orcid.org/0000-0001-5596-7831
Kiss, Zoltán
Rokszin, György
Abonyi-Tóth, Zsolt
Wittmann, István
Kempler, Péter
Article History
Received: 7 June 2018
First Online: 17 August 2018